Disclosures for "Rapid Clinical Improvement of Anti-HMGCR Immune-mediated Necrotizing Myopathy (IMNM) Treated with Efgartigimod"
-
Quantao Zeng has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose